Molecular characterization of a somatically mutated anti-DNA antibody bearing two systemic lupus erythematosus-related idiotypes

The Journal of Clinical Investigation
A DavidsonB Diamond

Abstract

We report the molecular characterization of 2A4, an IgG, DNA-binding antibody bearing the 3I and F4 idiotypes which are associated with anti-DNA antibodies in serum of patients with systemic lupus erythematosus (SLE). The antibody is produced by an EBV-transformed B cell line derived from a patient with multiple myeloma whose myeloma protein is also an IgG, 3I-reactive, F4-reactive, DNA-binding immunoglobulin, although the 2A4 antibody does not itself represent the myeloma protein. The 2A4 heavy chain is encoded by a VH4 gene, a D-D gene fusion and the JH6 gene; the light chain is derived from a Vk1 gene and the Jk2 gene. This is the first human antibody shown to have a CDR3 encoded by a D-D fusion. DNA sequence analysis of the 2A4 VH gene together with a Southern blot of genomic DNA probed with a 2A4 VH-specific oligonucleotide strongly suggest it to be somatically mutated. The data provide evidence that human autoantibodies can be products of somatically mutated genes and suggest that the 2A4 antibody may reflect the selective pressure of antigen.

References

Dec 1, 1977·European Journal of Immunology·J L Preud'hommeM Seligmann
Mar 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·N C SeemanA Rich
Jun 20, 1987·Journal of Molecular Biology·K H LeeT Honjo
Jun 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·S M Behar, M D Scharff
Nov 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·C Kocks, K Rajewsky
May 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·J GeliebterS G Nathenson
Jun 1, 1987·The Journal of Experimental Medicine·D M Klinman, A D Steinberg
Aug 2, 1987·Nature·M J ShlomchikM G Weigert
Aug 1, 1985·The Journal of Clinical Investigation·R HalpernB Diamond
Jul 11, 1984·Nucleic Acids Research·H R JaenichenH G Zachau
Feb 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·G SolomonB Diamond
Jan 1, 1983·Annals of the New York Academy of Sciences·B Diamond, G Solomon
Sep 1, 1983·The Journal of Experimental Medicine·Y ShoenfeldR S Schwartz
Apr 1, 1981·The Journal of Experimental Medicine·E M LaferB D Stollar
Jul 1, 1982·Arthritis and Rheumatism·B H Hahn

❮ Previous
Next ❯

Citations

Jan 5, 2002·Arthritis and Rheumatism·T Dörner, P E Lipsky
Jan 1, 1992·Journal of Clinical Immunology·A LivnehB Diamond
Oct 17, 1998·Clinical Reviews in Allergy & Immunology·P E SpronkC G Kallenberg
Jan 1, 1989·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·A DavidsonR Shefner
Dec 1, 1994·Current Opinion in Immunology·T Logtenberg
Jul 2, 1998·Clinical and Experimental Immunology·S C HuangE C Milner
Dec 1, 1991·The Journal of Experimental Medicine·A Manheimer-LoryB Diamond
Jul 1, 1992·The Journal of Experimental Medicine·A Manheimer-LoryB Diamond
Sep 1, 1994·The Journal of Experimental Medicine·J B KatzB Diamond
Jan 20, 1997·AIDS Research and Human Retroviruses·V L NgM S McGrath
May 1, 1992·British Journal of Haematology·M BouananiM Bastide
Aug 1, 1993·Scandinavian Journal of Immunology·V HurezM D Kazatchkine
Aug 1, 1992·Immunological Reviews·A K StewartR S Schwartz
May 1, 1991·The Journal of Clinical Investigation·A J Manheimer-LoryB A Diamond
Nov 20, 1997·The Journal of Clinical Investigation·A J Manheimer-LoryB Diamond
Nov 15, 2011·Arthritis Research & Therapy·Thomas DörnerPeter E Lipsky
Jul 6, 2010·Journal of Immunological Methods·Thomas DörnerPeter E Lipsky
May 1, 1992·Clinical Immunology and Immunopathology·R Suenaga, N I Abdou
Feb 1, 1995·Baillière's Clinical Rheumatology·A O Adebajo, D A Isenberg
Feb 9, 2000·Rheumatology·M L Stoll, J Gavalchin
Jan 1, 1992·Arthritis and Rheumatism·V Pascual, J D Capra
Apr 1, 1992·European Journal of Immunology·N P WengD M Marcus

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.